期刊文献+

痰热清与蒲地蓝联合治疗普通型手足口病疗效观察 被引量:2

Tanreqing and Pudilan combination therapy for HFMD clinical observation
下载PDF
导出
摘要 目的探讨痰热清与蒲地蓝联合治疗手足口病的疗效。方法将我院2011年住院普通手足口病患儿100例随机分为两组,治疗组50例给予蒲地蓝及痰热清,对照组50例给予痰热清治疗,所有病例组均给于补液、对症等一般治疗。比较两组患者的热退时间、皮疹消退时间、口腔炎愈合时间和总病程。结果观察组症状体征消退时间及总病程均少于对照组(P<0.01)。结论痰热清及蒲地蓝联合可有效治疗手足口病,且无明显副作用,值得临床推广使用。 Objective To explore two drugs combined application curative effects of HFMD.Methods Total of 100 patients with HFMD were randomly divided into two groups: one group were treated with Tangreqing and Pudilan,another group were treated with Tangreqing,and all the cases were given fluid infusion,such as fever general treatment.Thermal annealing time,skin rash subsided time,stomatitis healing time and total duration of symptoms were compared.Results Symptoms and signs subsided time and total duration of observation group were less than the control group.Conclusion Tanreqing and Pudilan combined application can be effective in treating pediatric HFMD.
出处 《青岛医药卫生》 2012年第1期42-44,共3页 Qingdao Medical Journal
关键词 痰热清 蒲地蓝 手足口病 Tanreqing Pudilan HFMD
  • 相关文献

参考文献6

二级参考文献16

  • 1Chronic obstructive pulmonary disease research group of chinese society for respiratory disease. Guideline for diagnosis and management of chronic obstructive pulmonary disease [ J ].Chinese Journal of Tuberculosis and Respiratory Diseases, 2002;25(8) :45
  • 2Balbi B, Majori M,Bertacco S, Convertino G, Cuomo A,Donner CF, Pesci A. Inhaled corticosteroids in stable COPD patients:do they have effects on cells and molecular mediators of airway inflammation [ J ] ? Chest, 2000; 117 ( 6 ): 1 633 -1 637
  • 3Keatings VM, Collin PD, Scott DM, Barnes PJ. Differences in intefieukin -8 and tumor necrosis factor -alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma[J]. Am J Respir Cdt Care Med,1996; 153:530- 534
  • 4De Boer WI, Sont JK, Van Schadewijk A, Stolk J, van Krieken JH, Hiemstra PS. Monocyte chemoattractant protein 1 ,interleukin 8, and chronic airways inflammation in COPD [J ].Journal of Pathol, 2000; 190 ( 5 ) :619 - 626
  • 5Riise GC,Ahlstedt S,Larsson S, Enander I, Jones I, Larsson P, Andersson B. Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid[J]. Thorax, 1995; 50:360 -365
  • 6Pesei A, Balbi B,Majori M. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease[J]. Eur Respir J, 1998; 12:380 -386
  • 7Tanino M,Betsuyaku T, Takeyabu K, Tanino Y, Yamaguchi E, Miyamoto K, Nishimura M. Increased levels of intefieukin -8 in BAL fluid from smokers susceptible to pulmonary emphysema[J]. Thorax, 2002; 57(5) :405 -411
  • 8Mikami M, Llewellyn -Jones CG, Bayley D,Hill SL,Stockley RA. The Chemotacfic Activity of Sputum from Patients with Bronchiectasis [ J ]. Am J Respir Crit Care Med,1998; 157:723 -728
  • 9Seggev JS, Thomton WH Jr,Edes TE. Serum leukotriene B4 levels in patient with obstructive pulmonary disease[J]. Chest,1991; 99:289 -291
  • 10Beeh KM, Korumann O,Buhl R,Culpitt SV, Giembycz MA, Bame PJ. Neutrophil Chemntachc Activity of Sputum From Patients With COPD: Role of Intedeukin 8 and Leukotriene B4[J]. Chest, 2003; 123(4) :1 240 -1 247

共引文献306

同被引文献50

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部